Denali Therapeutics Inc. (DNLI)

Denali Therapeutics Inc. (DNLI) is a healthcare company (biotechnology) based in the United States. The share price is $17.93, down 0.83% on the day, which values the company at $2.87B. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$17.93−0.83% today
Market value
$2.87B
200-week average
$20.9014% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Denali Therapeutics Inc. in more detail

DNLI trades at -7.9× next year's expected earnings, 134.4× sales. It sits 14% below its 200-week average of $20.90.

In its favour: More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

4 of the superinvestors tracked here hold DNLI, including Julian and Felix Baker (0.5% of the portfolio), Temasek (0.4% of the portfolio), Brandon Haley (0.2% of the portfolio).

Superinvestors holding DNLI

4 of the investors tracked here report a position in their latest 13F filing.

Denali Therapeutics Inc. (DNLI): questions and answers

What is Denali Therapeutics Inc.'s market cap?

Denali Therapeutics Inc. is valued at $2.87B at a share price of $17.93.

Is DNLI above its 200-week moving average?

No. DNLI is 14.2% below its 200-week average of $20.90. Long-term investors watch that line because strong companies rarely trade below it for long.

Does DNLI pay a dividend?

Denali Therapeutics Inc. does not currently pay a regular dividend.

Which famous investors own DNLI?

In their latest quarterly filings, Julian and Felix Baker (0.5% of the portfolio), Temasek (0.4% of the portfolio), Brandon Haley (0.2% of the portfolio), Baillie Gifford team (0.2% of the portfolio) hold DNLI. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Denali Therapeutics Inc. (DNLI) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/DNLI

Underlying data: Yahoo Finance; company filings with the SEC.